Product logins

Find logins to all Clarivate products below.


Laparoscopic Devices | Market Insights | Europe | 2022

Procedure deferrals due to the COVID-19 pandemic severely impacted the European laparoscopic device market in 2020, and the elective nature of many postponed procedures will hinder the pace of recovery to some extent. However, as the situation improves, the European laparoscopic device market will grow modestly through the forecast period, driven by continuing growth in laparoscopic procedures, increasing device penetration into procedures, and the adoption of premium-priced products, particularly in the direct energy device and endolinear stapler and cutter markets.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for laparoscopic devices in Europe across an 11-year period.

Related Medtech Insights Reports

Report
Laparoscopic Devices – Market Insights – Latin America
The Latin American laparoscopic device market is projected to experience modest growth through 2034. Growth over the forecast period will be driven mainly by the continued uptake of innovative…
Report
Interventional Oncology Devices – Market Insights – Europe
The European interventional oncology device market is projected to see modest growth through 2034, driven by rising cancer incidence and prevalence rates, updated clinical guidelines, and emerging…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be primarily driven by the high incidence of gastric cancer and CRC cases in the region. Growth will be supported by nationwide CRC and GI cancer…
Report
Urological Devices – Market Insights – Europe
The European urological device market is set to grow through 2034, driven by product innovation, rising awareness, increasing kidney stone cases, and an aging population. Growth will be led by BPH…
Report
Gynecological Devices – Market Insights – Europe
The European gynecological device market will see marginal growth over the forecast period, fueled by the ongoing adoption of office-based treatments, the increasing preference for minimally…